The VITA program, which the IRS administers, began after the Tax Reform Act of 1969 and provides free tax filing assistance ...
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback